Filing Details
- Accession Number:
- 0000950170-25-063831
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-05 20:28:36
- Reporting Period:
- 2025-05-02
- Filing Date:
- 2025-05-05
- Accepted Time:
- 2025-05-05 20:28:36
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1286199 | K Joseph Belanoff | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-02 | 18,480 | $72.52 | 2,963,505 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
Common Stock | Disposition | 2025-05-02 | 21,520 | $73.22 | 2,941,985 | No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
No | 4 | S | Indirect | Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 |
Footnotes
- This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024 in effect at the time of this transaction.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $72.13 to $72.99 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- Reporting Person has voting power over the shares held by the Joseph K. Belanoff and Katherine A. Blenko Revocable Living Trust DTD 04/29/02 pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein.
- Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $73.00 to $73.65 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.